Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2023 Filed May 1, 2023 23:47 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054644 · tm2314266-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,107 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:53 UTC |
Mead Dana G Jr.Director
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054655 · tm2314266-10_4seq1.xml · nonDerivative · entry 1 Mead Dana G Jr. · CIK 0001222358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,669 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:52 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054652 · tm2314266-9_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,992 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:51 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054649 · tm2314266-7_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:51 UTC |
Sparks Charisse YDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054650 · tm2314266-8_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:50 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054648 · tm2314266-6_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,268 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:48 UTC |
mcCormick ShawnDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054646 · tm2314266-4_4seq1.xml · nonDerivative · entry 1 McCormick Shawn · CIK 0001454092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,187 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:46 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054643 · tm2314266-2_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,894 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:45 UTC |
Griffin Jerry CDirector
|
GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054641 · tm2314266-1_4seq1.xml · nonDerivative · entry 1 Griffin Jerry C · CIK 0001327953 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,729 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 25, 2023 Filed May 3, 2023 20:35 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $42.15 | $0.00 |
DisclosureSEC source: 0001104659-23-055529 · tm2314578-1_4seq1.xml · derivative · entry 7 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,432 Underlying: Common Stock · 8,000 shares Expires 2028-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| April 25, 2023 Filed May 3, 2023 20:35 UTC |
Jandrich StevenVP, Human Resources
|
SaleCommon Stock | 2,100 | $273.03 | $573,363.00 |
DisclosureSEC source: 0001104659-23-055529 · tm2314578-1_4seq1.xml · nonDerivative · entry 4 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,371 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.00 to $273.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 25, 2023 Filed May 3, 2023 20:35 UTC |
Jandrich StevenVP, Human Resources
|
SaleCommon Stock | 401 | $271.20 | $108,751.20 |
DisclosureSEC source: 0001104659-23-055529 · tm2314578-1_4seq1.xml · nonDerivative · entry 3 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,471 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.08 to $271.49, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 25, 2023 Filed May 3, 2023 20:35 UTC |
Jandrich StevenVP, Human Resources
|
SaleCommon Stock | 5,499 | $270.24 | $1,486,049.76 |
DisclosureSEC source: 0001104659-23-055529 · tm2314578-1_4seq1.xml · nonDerivative · entry 2 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,872 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2022 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.78, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 25, 2023 Filed May 3, 2023 20:35 UTC |
Jandrich StevenVP, Human Resources
|
Exercise / conversionCommon Stock | 8,000 | $42.15 | $337,200.00 |
DisclosureSEC source: 0001104659-23-055529 · tm2314578-1_4seq1.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:07 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 59 | $231.77 | $13,674.43 |
DisclosureSEC source: 0001104659-23-044577 · tm2312581-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:11 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 56 | $231.77 | $12,979.12 |
DisclosureSEC source: 0001104659-23-044585 · tm2312581-6_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,599 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:09 UTC |
Sparks Charisse YDirector
|
GrantCommon Stock | 56 | $231.77 | $12,979.12 |
DisclosureSEC source: 0001104659-23-044582 · tm2312581-5_4seq1.xml · nonDerivative · entry 1 Sparks Charisse Y · CIK 0001940873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:06 UTC |
NELSON MARILYN CDirector
|
GrantCommon Stock | 91 | $231.77 | $21,091.07 |
DisclosureSEC source: 0001104659-23-044576 · tm2312581-3_4seq1.xml · nonDerivative · entry 1 NELSON MARILYN C · CIK 0001199894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,225 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:06 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 64 | $231.77 | $14,833.28 |
DisclosureSEC source: 0001104659-23-044573 · tm2312581-2_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 609 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:05 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 64 | $231.77 | $14,833.28 |
DisclosureSEC source: 0001104659-23-044565 · tm2312581-1_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,323 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:05 UTC |
mcCormick ShawnDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-23-035049 · tm2310036-1_4seq1.xml · derivative · entry 3 McCormick Shawn · CIK 0001454092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,519 Underlying: Common Stock · 4,000 shares Expires 2027-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. F2 · balance_after: The amount of options originally reported in the Reporting Person's Form 3 dated May 2, 2018 understated the number of shares of common stock underlying the option by one share. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:05 UTC |
mcCormick ShawnDirector
|
Exercise / conversionCommon Stock | 4,000 | $0.94 | $3,760.00 |
DisclosureSEC source: 0001104659-23-035049 · tm2310036-1_4seq1.xml · nonDerivative · entry 1 McCormick Shawn · CIK 0001454092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:24 UTC |
Rondoni JohnChief Technology Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,387 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001104659-23-031312 · tm239130-4_4seq1.xml · derivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 4,387 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:24 UTC |
Rondoni JohnChief Technology Officer
|
Exercise / conversionCommon Stock | 4,387 | $2.07 | $9,081.09 |
DisclosureSEC source: 0001104659-23-031312 · tm239130-4_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · derivative · entry 9 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,090 Underlying: Common Stock · 10,000 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 1,566 | $263.37 | $412,437.42 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.88 to $263.69, inclusive. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 900 | $261.54 | $235,386.00 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.27 to $262.06, inclusive. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 3,135 | $26,074.00 | $81,741,990.00 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.24 to $261.20, inclusive. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 3,222 | $259.74 | $836,882.28 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,905 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.23 to $260.12, inclusive. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
SaleCommon Stock | 1,177 | $258.62 | $304,395.74 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,127 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.13 to $259.09, inclusive. F3 · price: The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Ban RandyChief Commercial Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.94 | $9,400.00 |
DisclosureSEC source: 0001104659-23-028420 · tm238481-1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:07 UTC |
Jandrich StevenVP, Human Resources
|
GiftCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026893 · tm238158-1_4seq1.xml · nonDerivative · entry 5 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 478 F2 · kind: This transaction involved a gift of securities by the reporting person to his son, who shares the reporting person's household. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 01:07 UTC |
Jandrich StevenVP, Human Resources
|
GiftCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026893 · tm238158-1_4seq1.xml · nonDerivative · entry 4 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,371 F2 · kind: This transaction involved a gift of securities by the reporting person to his son, who shares the reporting person's household. Read SEC document |
| February 24, 2023 Filed Mar 1, 2023 01:07 UTC |
Jandrich StevenVP, Human Resources
|
GiftCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026893 · tm238158-1_4seq1.xml · nonDerivative · entry 3 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 478 F1 · kind: This transaction involved a gift of securities by the reporting person to his daughter, who shares the reporting person's household. Read SEC document |
| February 24, 2023 Filed Mar 1, 2023 01:07 UTC |
Jandrich StevenVP, Human Resources
|
GiftCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026893 · tm238158-1_4seq1.xml · nonDerivative · entry 2 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,499 F1 · kind: This transaction involved a gift of securities by the reporting person to his daughter, who shares the reporting person's household. Read SEC document |
| February 24, 2023 Filed Mar 1, 2023 01:07 UTC |
Jandrich StevenVP, Human Resources
|
GiftCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026893 · tm238158-1_4seq1.xml · nonDerivative · entry 1 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,627 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 23:54 UTC |
Ebeling PhilipChief Operating Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $194.82 | $0.00 |
DisclosureSEC source: 0001104659-23-023901 · tm237460-1_4seq1.xml · derivative · entry 3 Ebeling Philip · CIK 0001662781 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 Underlying: Common Stock · 7,000 shares Expires 2030-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option has vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 23:54 UTC |
Ebeling PhilipChief Operating Officer
|
SaleCommon Stock | 7,000 | $275.00 | $1,925,000.00 |
DisclosureSEC source: 0001104659-23-023901 · tm237460-1_4seq1.xml · nonDerivative · entry 2 Ebeling Philip · CIK 0001662781 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 23:54 UTC |
Ebeling PhilipChief Operating Officer
|
Exercise / conversionCommon Stock | 7,000 | $194.82 | $1,363,740.00 |
DisclosureSEC source: 0001104659-23-023901 · tm237460-1_4seq1.xml · nonDerivative · entry 1 Ebeling Philip · CIK 0001662781 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 11,715 | $275.17 | $3,223,616.55 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 24 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 17,889 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.94, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 14, 2023 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 1,496 | $276.18 | $413,165.28 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 23 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 29,604 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.00 to $276.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 14, 2023 Filed Mar 13, 2023 20:51 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 18,642 | $275.47 | $5,135,311.74 |
DisclosureSEC source: 0001104659-23-031810 · tm239130-3_4seq1.xml · nonDerivative · entry 22 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 31,100 F9 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Securities held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 00:51 UTC |
Herbert Timothy P.Director · CEO and President
|
SaleCommon Stock | 2,619 | $275.05 | $720,355.95 |
DisclosureSEC source: 0001104659-23-022076 · tm236006-4_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 9,728 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.19, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:57 UTC |
Rondoni JohnChief Technology Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022083 · tm236006-8_4seq1.xml · derivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 01:00 UTC |
Ebeling PhilipChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022085 · tm236006-9_4seq1.xml · derivative · entry 2 Ebeling Philip · CIK 0001662781 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 01:01 UTC |
Phillips Bryan KSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022089 · tm236006-10_4seq1.xml · derivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:55 UTC |
Ban RandyChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022082 · tm236006-7_4seq1.xml · derivative · entry 1 Ban Randy · CIK 0001737127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:53 UTC |
Buchholz RichardChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022080 · tm236006-6_4seq1.xml · derivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:52 UTC |
Jandrich StevenVP, Human Resources
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022079 · tm236006-5_4seq1.xml · derivative · entry 1 Jandrich Steven · CIK 0001737203 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock · 5,450 shares Expires 2033-02-10 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 10, 2023 Filed Feb 15, 2023 00:51 UTC |
Herbert Timothy P.Director · CEO and President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,439 | $0.00 Strike: $263.16 | $0.00 |
DisclosureSEC source: 0001104659-23-022076 · tm236006-4_4seq1.xml · derivative · entry 6 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,439 Underlying: Common Stock · 20,439 shares Expires 2033-02-10 F7 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 10, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.